184 related articles for article (PubMed ID: 10919317)
1. Part V. Adjuvant therapies for ductal carcinoma in situ.
Kim JJ
Curr Probl Cancer; 2000; 24(3):163-74. PubMed ID: 10919317
[No Abstract] [Full Text] [Related]
2. [Radiotherapy of breast carcinoma. 2005 version].
Organgruppe "Mammakarzinom" der DEGRO
Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
[No Abstract] [Full Text] [Related]
3. Ductal carcinoma in situ, complexities and challenges.
Leonard GD; Swain SM
J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma-in-situ.
Wickerham DL
J Clin Oncol; 2001 Sep; 19(18 Suppl):98S-100S. PubMed ID: 11560982
[No Abstract] [Full Text] [Related]
5. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
[TBL] [Abstract][Full Text] [Related]
6. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
Allred DC; Anderson SJ; Paik S; Wickerham DL; Nagtegaal ID; Swain SM; Mamounas EP; Julian TB; Geyer CE; Costantino JP; Land SR; Wolmark N
J Clin Oncol; 2012 Apr; 30(12):1268-73. PubMed ID: 22393101
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
Cunnick GH; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
[TBL] [Abstract][Full Text] [Related]
9. Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.
Guerrieri-Gonzaga A; Sestak I; Lazzeroni M; Serrano D; Rotmensz N; Cazzaniga M; Varricchio C; Pruneri G; Leonardi MC; Orecchia R; Galimberti V; Bonanni B; DeCensi A
Int J Cancer; 2016 Nov; 139(9):2127-34. PubMed ID: 27381855
[TBL] [Abstract][Full Text] [Related]
10. Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.
Newman LA
J Natl Cancer Inst Monogr; 2010; 2010(41):152-7. PubMed ID: 20956822
[TBL] [Abstract][Full Text] [Related]
11. [Controversies in breast conservation treatment for breast cancer].
Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
Sautter-Bihl ML
Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
[No Abstract] [Full Text] [Related]
13. The impact of systemic therapy following ductal carcinoma in situ.
Eng-Wong J; Costantino JP; Swain SM
J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830
[TBL] [Abstract][Full Text] [Related]
14. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
; Correa C; McGale P; Taylor C; Wang Y; Clarke M; Davies C; Peto R; Bijker N; Solin L; Darby S
J Natl Cancer Inst Monogr; 2010; 2010(41):162-77. PubMed ID: 20956824
[TBL] [Abstract][Full Text] [Related]
15. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
16. Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
Fujita T
Ann Surg; 2011 Jun; 253(6):1233; author reply 1233-4. PubMed ID: 21522008
[No Abstract] [Full Text] [Related]
17. Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis.
Staley H; McCallum I; Bruce J
Breast; 2014 Oct; 23(5):546-51. PubMed ID: 25023044
[TBL] [Abstract][Full Text] [Related]
18. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.
Solin LJ
J Natl Cancer Inst Monogr; 2010; 2010(41):187-92. PubMed ID: 20956827
[TBL] [Abstract][Full Text] [Related]
19. Can some DCIS patients avoid adjuvant therapy? Still unknown.
Schmidt C
J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062
[No Abstract] [Full Text] [Related]
20. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
Buchholz TA; Haffty BG; Harris JR
J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
